You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
The cholesterol-lowering drug Pravachol (pravastatin), when administered at 40 milligrams per day over six years, helps prevent cardiovascular events including stroke in people with diabetes or with impaired fasting glucose (IFG) and established coronary disease.
The LIPID trial (long-term intervention with pravastatin in ischemic disease) conducted in Australia studied 9,014 patients including 1,077 with diabetes and 940 with IFG.
Use of Pravachol reduced the risk of any cardiovascular event from 52.7 to 45.2 percent in subjects with diabetes and reduced the risk of stroke from 9.9 to 6.3 percent. However, it did not reduce the incidence of diabetes in those not previously diagnosed.
Treatment with “statin” drugs to lower cholesterol does pay off, however.
Use of pravastatin prevented one major coronary event (death or nonfatal myocardial infarction) over a six-year period in 23 patients with IFG and 18 patients with diabetes.
In the placebo-treated group the risk of a major coronary disease event was 61 percent higher in subjects with diabetes and 23 percent higher in those with IFG than in subjects with normal fasting glucose.
Diabetes Care, October 2003
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.